InsidersTradesSigma
Follow the 페니트리움바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 페니트리움바이오 has published 1 public disclosures. Market capitalisation: €235.9bn. The latest transaction was disclosed on 26 March 2026 (Other). Among the most active insiders: 현대바이오. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
페니트리움바이오 operates in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative biopharmaceutical solutions.